Condition: Dialysis; Complications · Vascular Access Complication · Sponsor: Voyager Biomedical
This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
This description comes directly from the study's public registry record.
Britnee Ochabski · 9493224050 · bochabski@voyagerbiomedical.com
Supraj Amunje · samunje@voyagerbiomedical.com
Always discuss trial participation with your own doctor first.
| Trinity Research Group | Dothan, Alabama, United States | Recruiting |
| Apex Research | Riverside, California, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| Northwell Health | Hyde Park, New York, United States | Recruiting |
| MUSC Health Orangeburg | Orangeburg, South Carolina, United States | Recruiting |
| Cardiothoracic and Vascular Surgeons | Austin, Texas, United States | Recruiting |
| Baylor Scott & White | Dallas, Texas, United States | Recruiting |
| Fairlawn Surgery Center | Roanoke, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05490225